Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

about

Management of chronic pain in osteoporosis: challenges and solutions Strontium ranelate improves delayed healing of osteolytic lesions of the jaw in a man with chronic osteomyelitis. Case report Modulation of Osteoclast Interactions with Orthopaedic Biomaterials.

P2860

Q26751333-BB2C2CD4-A0AF-49EE-B0C6-365C2B77418A Q33781635-D6164042-2FF2-4D03-9A30-9112B6AE6B0F Q55111648-4B7A0995-CAAB-448C-9FAD-13F913DED84E

P2860

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

Item

http://www.wikidata.org/entity/Q36505624

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

@ast

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

@en

type

Item

label

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

@ast

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

@en

prefLabel

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

@ast

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

@en

P1476

Healing of subtrochanteric atypical fractures after strontium ranelate treatment

@en

P2093

Armando Luis Negri

http://www.w3.org/2001/XMLSchema#string

Francisco Rodolfo Spivacow

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

Severely suppressed bone turnover: a potential complication of alendronate therapy.

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Mechanisms of action and therapeutic potential of strontium in bone.

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

P304

166-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23289032

http://www.w3.org/2001/XMLSchema#string

P932

3535996

http://www.w3.org/2001/XMLSchema#string

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

about

P2860

P2860

Healing of subtrochanteric atypical fractures after strontium ranelate treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932